Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 126 entries
Sorted by: Best Match Show Resources per page
Recent advances in telepsychiatry: an updated review

program design

Frueh BC.
GSID: nFsGFJLk64QJ
J Monnier, RG Knapp, BC Frueh - Psychiatric Services, 2003 - Am Psychiatric Assoc

OBJECTIVE: In response to new developments and interest in the area of telepsychiatry, literature on this topic has greatly increased over the past three years. Because of this …

Cite
Monnier, J., Knapp, R. G., & Frueh, B. C. (2003). Recent advances in telepsychiatry: an updated review. Psychiatric Services, 54(12), 1604-1609.
Monnier, Jeannine, Rebecca G. Knapp, and B. Christopher Frueh. "Recent advances in telepsychiatry: an updated review." Psychiatric Services 54.12 (2003): 1604-1609.
Copy Download .nbib Format: MLA
Procedural and methodological issues in telepsychiatry research and program development

program design

Frueh BC, Gold PB.
GSID: Wxu9wbXNTpsJ
BC Frueh, SE Deitsch, AB Santos, PB Gold… - Psychiatric …, 2000 - Am Psychiatric Assoc

… future research: study design, outcome measurement, consideration of patient characteristics, and program design. … Program design and implementation … changes and have the opportunity to participate in program development and implementation. The unique aspects of …

Cite
Frueh, B. C., Deitsch, S. E., Santos, A. B., Gold, P. B., Johnson, M. R., Meisler, N., ... & Ballenger, J. C. (2000). Procedural and methodological issues in telepsychiatry research and program development. Psychiatric Services, 51(12), 1522-1527.
Frueh, B. Christopher, et al. "Procedural and methodological issues in telepsychiatry research and program development." Psychiatric Services 51.12 (2000): 1522-1527.
Copy Download .nbib Format: MLA
Adult psychopathology and diagnosis

adult

Beidel DC, Frueh BC.
GSID: PQcEHDu0sKUJ
DC Beidel, BC Frueh - 2018 - books.google.com

The definitive resource for psychological diagnosis, updated with the latest research Adult Psychopathology and Diagnosis offers comprehensive coverage of psychological disorders …

Cite
Beidel, D. C., & Frueh, B. C. (Eds.). (2018). Adult psychopathology and diagnosis. John Wiley & Sons.
Beidel, Deborah C., and B. Christopher Frueh, eds. Adult psychopathology and diagnosis. John Wiley & Sons, 2018.
Copy Download .nbib Format: MLA
Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound.

Nanoscale

Gai M, Frueh J, Tao T, Petrov AV, Petrov VV, Shesterikov EV, Tverdokhlebov SI, Sukhorukov GB.
PMID: 28513733
Nanoscale. 2017 Jun 01;9(21):7063-7070. doi: 10.1039/c7nr01841j.

Long term encapsulation combined with spatiotemporal release for a precisely defined quantity of small hydrophilic molecules on demand remains a challenge in various fields ranging from medical drug delivery, controlled release of catalysts to industrial anti-corrosion systems. Free-standing individually...

Cite
Gai M, Frueh J, Tao T, et al. Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound. Nanoscale. 2017;9(21):7063-7070doi: 10.1039/c7nr01841j.
Gai, M., Frueh, J., Tao, T., Petrov, A. V., Petrov, V. V., Shesterikov, E. V., Tverdokhlebov, S. I., & Sukhorukov, G. B. (2017). Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound. Nanoscale, 9(21), 7063-7070. https://doi.org/10.1039/c7nr01841j
Gai, Meiyu, et al. "Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound." Nanoscale vol. 9,21 (2017): 7063-7070. doi: https://doi.org/10.1039/c7nr01841j
Gai M, Frueh J, Tao T, Petrov AV, Petrov VV, Shesterikov EV, Tverdokhlebov SI, Sukhorukov GB. Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound. Nanoscale. 2017 Jun 01;9(21):7063-7070. doi: 10.1039/c7nr01841j. PMID: 28513733.
Copy Download .nbib Format: NLM
Intensive inpatient treatment improves emotion-regulation capacities among adults with severe mental illness.

Borderline personality disorder and emotion dysregulation

Fowler JC, Allen JG, Hart JM, Szlykh H, Ellis TE, Frueh BC, Oldham JM.
PMID: 26401302
Borderline Personal Disord Emot Dysregul. 2014 Dec 15;1:19. doi: 10.1186/2051-6673-1-19. eCollection 2014.

BACKGROUND: Impaired capacity for emotion regulation is associated with a broad spectrum of psychiatric disturbances; however, little is known about treatment response in emotion regulation functioning among patients with severe mental illness. This study examined treatment response and the...

Cite
Fowler JC, Allen JG, Hart JM, et al. Intensive inpatient treatment improves emotion-regulation capacities among adults with severe mental illness. Borderline Personal Disord Emot Dysregul. 2014;1:19doi: 10.1186/2051-6673-1-19.
Fowler, J. C., Allen, J. G., Hart, J. M., Szlykh, H., Ellis, T. E., Frueh, B. C., & Oldham, J. M. (2014). Intensive inpatient treatment improves emotion-regulation capacities among adults with severe mental illness. Borderline personality disorder and emotion dysregulation, 119. https://doi.org/10.1186/2051-6673-1-19
Fowler, J Christopher, et al. "Intensive inpatient treatment improves emotion-regulation capacities among adults with severe mental illness." Borderline personality disorder and emotion dysregulation vol. 1 (2014): 19. doi: https://doi.org/10.1186/2051-6673-1-19
Fowler JC, Allen JG, Hart JM, Szlykh H, Ellis TE, Frueh BC, Oldham JM. Intensive inpatient treatment improves emotion-regulation capacities among adults with severe mental illness. Borderline Personal Disord Emot Dysregul. 2014 Dec 15;1:19. doi: 10.1186/2051-6673-1-19. eCollection 2014. PMID: 26401302; PMCID: PMC4579521.
Copy Download .nbib Format: NLM
SCREENING FOR PTSD AMONG INCARCERATED MEN: A Comparative Analysis of Computer-Administered and Orally Administered Modalities.

Criminal justice and behavior

Wolff N, Gregory Chugo M, Shi J, Huening J, Frueh BC.
PMID: 25673900
Crim Justice Behav. 2015 Feb;42(2):219-236. doi: 10.1177/0093854814551601.

Trauma exposure is overrepresented in incarcerated male populations and is linked to psychiatric morbidity, particularly posttraumatic stress disorder (PTSD). This study tests the feasibility, reliability, and validity of using computer-administered interviewing (CAI) versus orally administered interviewing (OAI) to screen...

Cite
Wolff N, Gregory Chugo M, Shi J, et al. SCREENING FOR PTSD AMONG INCARCERATED MEN: A Comparative Analysis of Computer-Administered and Orally Administered Modalities. Crim Justice Behav. 2015;42(2):219-236doi: 10.1177/0093854814551601.
Wolff, N., Gregory Chugo, M., Shi, J., Huening, J., & Frueh, B. C. (2015). SCREENING FOR PTSD AMONG INCARCERATED MEN: A Comparative Analysis of Computer-Administered and Orally Administered Modalities. Criminal justice and behavior, 42(2), 219-236. https://doi.org/10.1177/0093854814551601
Wolff, Nancy, et al. "SCREENING FOR PTSD AMONG INCARCERATED MEN: A Comparative Analysis of Computer-Administered and Orally Administered Modalities." Criminal justice and behavior vol. 42,2 (2015): 219-236. doi: https://doi.org/10.1177/0093854814551601
Wolff N, Gregory Chugo M, Shi J, Huening J, Frueh BC. SCREENING FOR PTSD AMONG INCARCERATED MEN: A Comparative Analysis of Computer-Administered and Orally Administered Modalities. Crim Justice Behav. 2015 Feb;42(2):219-236. doi: 10.1177/0093854814551601. PMID: 25673900; PMCID: PMC4321801.
Copy Download .nbib Format: NLM
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information.

Journal of personalized medicine

Stanek EJ, Sanders CL, Frueh FW.
PMID: 25562522
J Pers Med. 2013 Jun 10;3(2):111-23. doi: 10.3390/jpm3020111.

We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory...

Cite
Stanek EJ, Sanders CL, Frueh FW. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J Pers Med. 2013;3(2):111-23doi: 10.3390/jpm3020111.
Stanek, E. J., Sanders, C. L., & Frueh, F. W. (2013). Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. Journal of personalized medicine, 3(2), 111-23. https://doi.org/10.3390/jpm3020111
Stanek, Eric J, et al. "Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information." Journal of personalized medicine vol. 3,2 (2013): 111-23. doi: https://doi.org/10.3390/jpm3020111
Stanek EJ, Sanders CL, Frueh FW. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J Pers Med. 2013 Jun 10;3(2):111-23. doi: 10.3390/jpm3020111. PMID: 25562522; PMCID: PMC4251399.
Copy Download .nbib Format: NLM
Collaborative care needs and preferences of primary care patients with multimorbidity.

Health expectations : an international journal of public participation in health care and health policy

Noël PH, Frueh BC, Larme AC, Pugh JA.
PMID: 15713171
Health Expect. 2005 Mar;8(1):54-63. doi: 10.1111/j.1369-7625.2004.00312.x.

OBJECTIVE To explore the collaborative care needs and preferences in primary care patients with multiple chronic illnesses. DESIGN Focus groups utilizing a series of open-ended questions elicited self-identified problems, experiences in communicating with providers, self-management needs, and preferences for...

Cite
Noël PH, Frueh BC, Larme AC, et al. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expect. 2005;8(1):54-63doi: 10.1111/j.1369-7625.2004.00312.x.
Noël, P. H., Frueh, B. C., Larme, A. C., & Pugh, J. A. (2005). Collaborative care needs and preferences of primary care patients with multimorbidity. Health expectations : an international journal of public participation in health care and health policy, 8(1), 54-63. https://doi.org/10.1111/j.1369-7625.2004.00312.x
Noël, Polly Hitchcock, et al. "Collaborative care needs and preferences of primary care patients with multimorbidity." Health expectations : an international journal of public participation in health care and health policy vol. 8,1 (2005): 54-63. doi: https://doi.org/10.1111/j.1369-7625.2004.00312.x
Noël PH, Frueh BC, Larme AC, Pugh JA. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expect. 2005 Mar;8(1):54-63. doi: 10.1111/j.1369-7625.2004.00312.x. PMID: 15713171; PMCID: PMC5060269.
Copy Download .nbib Format: NLM
Patient satisfaction among combat veterans receiving specialty PTSD treatment.

Journal of psychiatric practice

Frueh BC, Pellegrin KL, Elhai JD, Hamner MB, Gold PB, Magruder KM, Arana GW.
PMID: 15985896
J Psychiatr Pract. 2002 Sep;8(5):326-32. doi: 10.1097/00131746-200209000-00010.

BACKGROUND: Despite the difficulties with successfully developing effective treatments for posttraumatic stress disorder (PTSD), very little research has been conducted on veterans' perceptions of satisfaction with the treatments they receive through the VA.OBJECTIVE: Our objective was to evaluate combat...

Cite
Frueh BC, Pellegrin KL, Elhai JD, et al. Patient satisfaction among combat veterans receiving specialty PTSD treatment. J Psychiatr Pract. 2002;8(5):326-32doi: 10.1097/00131746-200209000-00010.
Frueh, B. C., Pellegrin, K. L., Elhai, J. D., Hamner, M. B., Gold, P. B., Magruder, K. M., & Arana, G. W. (2002). Patient satisfaction among combat veterans receiving specialty PTSD treatment. Journal of psychiatric practice, 8(5), 326-32. https://doi.org/10.1097/00131746-200209000-00010
Frueh, B Christopher, et al. "Patient satisfaction among combat veterans receiving specialty PTSD treatment." Journal of psychiatric practice vol. 8,5 (2002): 326-32. doi: https://doi.org/10.1097/00131746-200209000-00010
Frueh BC, Pellegrin KL, Elhai JD, Hamner MB, Gold PB, Magruder KM, Arana GW. Patient satisfaction among combat veterans receiving specialty PTSD treatment. J Psychiatr Pract. 2002 Sep;8(5):326-32. doi: 10.1097/00131746-200209000-00010. PMID: 15985896.
Copy Download .nbib Format: NLM
Noninferiority and equivalence designs: issues and implications for mental health research.

Journal of traumatic stress

Greene CJ, Morland LA, Durkalski VL, Frueh BC.
PMID: 18956449
J Trauma Stress. 2008 Oct;21(5):433-9. doi: 10.1002/jts.20367.

The terms noninferiority and equivalence are often used interchangeably to refer to trials in which the primary objective is to show that a novel intervention is as effective as the standard intervention. The use of these designs is becoming...

Cite
Greene CJ, Morland LA, Durkalski VL, et al. Noninferiority and equivalence designs: issues and implications for mental health research. J Trauma Stress. 2008;21(5):433-9doi: 10.1002/jts.20367.
Greene, C. J., Morland, L. A., Durkalski, V. L., & Frueh, B. C. (2008). Noninferiority and equivalence designs: issues and implications for mental health research. Journal of traumatic stress, 21(5), 433-9. https://doi.org/10.1002/jts.20367
Greene, Carolyn J, et al. "Noninferiority and equivalence designs: issues and implications for mental health research." Journal of traumatic stress vol. 21,5 (2008): 433-9. doi: https://doi.org/10.1002/jts.20367
Greene CJ, Morland LA, Durkalski VL, Frueh BC. Noninferiority and equivalence designs: issues and implications for mental health research. J Trauma Stress. 2008 Oct;21(5):433-9. doi: 10.1002/jts.20367. PMID: 18956449; PMCID: PMC2696315.
Copy Download .nbib Format: NLM
Pharmacogenomics steps toward personalized medicine.

Personalized medicine

Xie HG, Frueh FW.
PMID: 29788578
Per Med. 2005 Nov;2(4):325-337. doi: 10.2217/17410541.2.4.325.

The goal of personalized medicine is to maximize the likelihood of therapeutic efficacy and to minimize the risk of drug toxicity for an individual patient. One of the major contributors to this concept is pharmacogenomics. Marked interindividual genetic variation...

Cite
Xie HG, Frueh FW. Pharmacogenomics steps toward personalized medicine. Per Med. 2005;2(4):325-337doi: 10.2217/17410541.2.4.325.
Xie, H. G., & Frueh, F. W. (2005). Pharmacogenomics steps toward personalized medicine. Personalized medicine, 2(4), 325-337. https://doi.org/10.2217/17410541.2.4.325
Xie, Hong-Guang, and Frueh, Felix W. "Pharmacogenomics steps toward personalized medicine." Personalized medicine vol. 2,4 (2005): 325-337. doi: https://doi.org/10.2217/17410541.2.4.325
Xie HG, Frueh FW. Pharmacogenomics steps toward personalized medicine. Per Med. 2005 Nov;2(4):325-337. doi: 10.2217/17410541.2.4.325. PMID: 29788578.
Copy Download .nbib Format: NLM
Modulation of Replicative Lifespan in .

Frontiers in microbiology

Bouklas T, Jain N, Fries BC.
PMID: 28194146
Front Microbiol. 2017 Jan 30;8:98. doi: 10.3389/fmicb.2017.00098. eCollection 2017.

The fungal pathogen,

Cite
Bouklas T, Jain N, Fries BC. Modulation of Replicative Lifespan in . Front Microbiol. 2017;8:98doi: 10.3389/fmicb.2017.00098.
Bouklas, T., Jain, N., & Fries, B. C. (2017). Modulation of Replicative Lifespan in . Frontiers in microbiology, 898. https://doi.org/10.3389/fmicb.2017.00098
Bouklas, Tejas, et al. "Modulation of Replicative Lifespan in ." Frontiers in microbiology vol. 8 (2017): 98. doi: https://doi.org/10.3389/fmicb.2017.00098
Bouklas T, Jain N, Fries BC. Modulation of Replicative Lifespan in . Front Microbiol. 2017 Jan 30;8:98. doi: 10.3389/fmicb.2017.00098. eCollection 2017. PMID: 28194146; PMCID: PMC5276861.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 126 entries